A modern research facility will be located at Podole street in Kraków-Ruczaj, in the neighborhood of the headquarters of the investor Ryvu Therapeutics S.A. (Selvita S.A.) It is polish, one of the largest biotechnology companies in Europe, conducting research on new oncology drugs. Mota-Engil Central Europe has 15 months to complete the investment.

• Total area: 10 015 m2
• Usable area: 8,270 m2
• Number of storeys: 6
Including above - ground: 5
Including underground: 1
• Building height: 24.52 m
• Building length: 46.5 m
• Building width: 36.55 m
• Building area: 1 699 m2
• Gross volume: 47 350 m3


CLIENT:
Ryvu Therapeutics S.A. (Selvita S.A.)

https://youtu.be/BDW3uQlgvQk